Combimatrix (CBMX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Combimatrix (CBMX)

CBMX 6.250

0.0%

Nov 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Lee who wrote (228)	8/16/2010 6:41:31 AM
From: Jeff Jordan	of 237

This didn't work out very well, Kumar was doing a better job? I was thinking this could have become a little Amgen, I'm glad I waited to see.....now they have another guy and a restructure, I guess I'm done watching? >>Mr. McGowan received his Bachelor of Science in Microbiology, with a focus in Genomics and Molecular Genetics, from Michigan State University. "We are pleased to have Mark join our Board at a time when CombiMatrix can benefit from his background in marketing, strategy, and analytics at firms like P&G and Johnson & Johnson," stated Dr. Amit Kumar, President and CEO of CombiMatrix. "Mark brings a fresh perspective to the company with his finance expertise, as well as his operational experience at some of the most respected companies in the world."<<<<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next